Research & Education

Increased Survival in Patients with Metastatic NSCLC Receiving Treatment in Academic Centers

Patients with metastatic NSCLC receiving treatment at academic centers (ACs) have an increased 2-year survival compared to patients treated at community-based centers (CCs).

Active Surveillance of Lung Subsolid Nodules Reduces Unnecessary Surgery and Overtreatment

Subsolid nodules (SSN) can be considered a biomarker of lung cancer risk and should be managed with long-term active surveillance.

Racial-Ethnic Disparities in the Quality of End-of-Life Care Among Lung Cancer Patients

Significant disparities in the quality of end-of-life lung cancer care were found among racial-ethnic minorities, with higher odds of experiencing potentially preventable medical encounters during end-of-life as compared with non-Hispanic whites.

Chemoradiation in Elderly Patients with Stage III NSCLC Improves Overall Survival

Elderly patients with stage III non-small cell lung cancer (NSCLC) showed improved overall survival (OS) when treated with chemoradiation (CRT) compared to definitive radiation (RT) alone.

Lung Cancer Clinical Trial Eligibility Criteria and Requirements Have Increased in Number and Complexity

Eligibility criteria continue to increase in number and complexity for lung cancer clinical trials.

Scientific Advances in Thoracic Oncology in 2016 Highlighted by the IASLC

DENVER – Capturing and summarizing the remarkable progress in lung cancer prevention, diagnosis, staging and treatment in 2016, the International Association for the Study of Lung Cancer (IASLC) announces the second annual publication of “Scientific Advances in Thoracic Oncology,” available online now and in the August 2017 issue of the IASLC’s Journal of Thoracic Oncology (JTO).

Pages